ClinicalTrials.gg
RecruitingNCT06357143Updated Apr 8, 2026

Efficacy of Early Multimodal Physiotherapy in Patients With Reverse Shoulder Prosthesis

An interventional study of REMOVE and CONTROL in Shoulder Fractures and Prosthesis User, sponsored by University of Malaga. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-04-08.

Sponsored by University of Malaga · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Sep 2025; still recruiting 1 year 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Shoulder Fractures with a site in Spain — 2 open to participants now, 3 under way, none of them phase 3. Shoulder Fractures · Spain.

Started
2025
the only one that year
No phase
4 of 11
1 open now
Registered
11th of 11
by date
Lead sponsor
1 of 11
University of Malaga

Among the 11 studies in Shoulder Fractures with a site in Spain, this one is the only one that started in 2025, is one of 4 with no phase, and was the 11th registered.

Shoulder Fractures

113 studies on the registry are indexed under Shoulder Fractures; 30 are open to participants now.

Browse Shoulder Fractures studies →

Open to participants now

2 of the 11 studies in Shoulder Fractures with a site in Spain are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 18 Shoulder Fractures studies recruiting now, 13 (72%) set no upper age limit and 3 (17%) stop at 75 or younger; 4 take children under 18; 2 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Shoulder Fractures with a site in Spain, or all of them as a file.
02

Study summary

The present study try to evaluate the effectivenness of an early intervention program based on multimodal physiotherapy and focused on therapeutic exercise to improve the results of patients with a reverse shoulder phrostesis. This trial will be a randomized controlled trial with parallel groups, and outcomes variables will include psychometric properties through the use of specific questionnaries, and laboratory variables such as strength with a dynamometer, range of movement with a goniometer, muscle mass with an ultrasound, and kinematic parameters with inertial sensors. This study aims to develop an original intervention program in order to try to establish new protocols in the management of these patients.

Read the detailed description

Background: Shoulder fractures, shoulder osteoarthritis and rheumatoid arthritis have a high prevalence and many times they require a surgery, in which a reverse shoulder phrostesis is colocated. Nonetheless, nowadays there is no a clear consensus protocol in order to manage the prehabilitation and rehabilitation of this patient, so each physiotherapist use different techniques to treat this pathology.

Objective: This study aims to evaluate the effectiveness of an original intervention program (REMOVE program) focused on an early intervention based on therapeutic exercise, manual therapy and education to improve the functionality of these patients after surgery.

Methods: This study is a randomized controlled trial with parallel groups. The control group receive standard care, and the experimental group is subjected to the REMOVE program. Both groups are evaluated five times, pre-surgery, at baseline, at 6 weeks, at 12 weeks and at 24 weeks to assess psychometric and laboratory outcomes.

03

Conditions studied

  • Shoulder Fractures
  • Prosthesis User

Browse trials for

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults with a reverse shoulder prosthesis.
  • Age between 18 and 90 years.
  • Signed .

Exclusion criteria

Exclusion Criteria:

  • Language or cultural barriers.
  • Other upper limb injury.
  • Treatment that affect physical activity capacity.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    CONTROL GROUP - STANDARD PHYSIOTHERAPY

    Patients will undergo standard care which consists of an initial consultation with the physiotherapist to receive some recommendations about exercises, progression and health education

    Other: CONTROL

  • Experimental
    EXPERIMENTAL GROUP - REMOVE PROGRAM

    INITIAL STAGE: * Aim: Recover mobility * Exercises: Passive therapy, isometric exercises focused on middle deltoid. * Goal: 80º passive flexion, 45º abduction, 5 N of abduction force STRENGTHENING STAGE * Aim: Enhance scapulohumeral rhythm and strength rotator cura * Exercises: Active-assisted therapy, isotonic exercises between 45-90º of forward flexión and abduction with dumbbells and isometric exercises focused on internal and external rotation. * Goal: 100º passive flexion, 90º lateral abduction, 10 N of abduction force INTENSIVE STAGE * Aim: Improve motor control and increase cross-sectional muscular área * Exercises: Rowe with resistance band, wall push ups, lateral elevation with dumbbles, active external and internal rotation. * Goal: 15 N of abduction force FUNCTIONAL STAGE * Aim: Develope daily life activities * Exercises: Overhead tasks, rowe with Kettlebell, internal and external rotations with resistance bands * Goal: 20 N of abduction force

    Other: REMOVE

Interventions

  • OtherREMOVE

    INITIAL STAGE: * Aim: Recover mobility * Exercises: Passive therapy, isometric exercises focused on middle deltoid. * Goal: 80º passive flexion, 45º abduction, 5 N of abduction force STRENGTHENING STAGE * Aim: Enhance scapulohumeral rhythm and strength rotator cura * Exercises: Active-assisted therapy, isotonic exercises between 45-90º of forward flexión and abduction with dumbbells and isometric exercises focused on internal and external rotation. * Goal: 100º passive flexion, 90º lateral abduction, 10 N of abduction force INTENSIVE STAGE * Aim: Improve motor control and increase cross-sectional muscular área * Exercises: Rowe with resistance band, wall push ups, lateral elevation with dumbbles, active external and internal rotation. * Goal: 15 N of abduction force FUNCTIONAL STAGE * Aim: Develope daily life activities * Exercises: Overhead tasks, rowe with Kettlebell, internal and external rotations with resistance bands * Goal: 20 N of abduction force

  • OtherCONTROL

    Patients will undergo standard care which consists of an initial consultation with the physiotherapist to receive some recommendations about exercises, progression and health education

06

What researchers measure

Primary outcomes

  1. American Shoulder and Elbow Surgeons Scale (ASES) - Functionality.

    This tool is used to evaluate functionality and shoulder-related problems. This scale contains demographic data, medical evaluation, and self-reported outcomes, with a visual analog scale (VAS) to report pain, and 10 items regarding daily life activities. The score is calculated: \[(10 - score obtained in VAS) x 5\] + (5/3 x score obtained in daily life activities)\]. The worst result is 0 points and the best one is 100 points.

    Time frame: BASELINE, 12 WEEKS, 24 WEEKS

Secondary outcomes

  1. Ultrasound image - Muscle thickness in centimeters.

    To measure the thickness of lateral deltoid muscle at rest, at maximum contraction, and fatigued, being able to compare the muscle mass variation between presurgical and postsurgical situation, and the effect of the intervention in this variable.

    Time frame: BASELINE, 12 WEEKS, 24 WEEKS

  2. Inertial sensors - Linear acceleration and angular velocity

    To assess kinematics variables such as angular velocity and linear acceleration during flexion, abduction and scaption, to evaluate the scapulohumeral rhythm and the tridimensional scapula motion.

    Time frame: BASELINE, 12 WEEKS, 24 WEEKS

  3. Dynamometer - Strength in Newtons.

    To measure strength, time to peak, rate of force development, and muscle power of the lateral deltoid.

    Time frame: BASELINE, 12 WEEKS, 24 WEEKS

  4. Goniometer - Range of motion in degrees.

    To measure the range of motion, both passive and active, in flexion, abduction, external rotation and internal rotation.

    Time frame: BASELINE, 12 WEEKS, 24 WEEKS

  5. Constant-Murley Score (CS) - Functionality

    To evaluate functional status of the shoulder. The scale is divided into four subscales: pain (15 points), activities of daily living (20 points), strength (25 points) and range of motion (40 points). The total score is between 0 points (worst result) and 100 points (best result).

    Time frame: BASELINE, 12 WEEKS, 24 WEEKS

  6. University of California - Los Angeles Shoulder Scale (UCLA) - Functionality.

    To assess functional outcomes after shoulder interventions. The scale include five categories: active forward flexion (5 points), strength of forward flexion (5 points), pain (10 points), satisfaction (5 points), and function (10 points). The total score range from 0 points (worst result) and 35 points (best result).

    Time frame: BASELINE, 12 WEEKS, 24 WEEKS

  7. Simple Shoulder Test (SST) - Functionality.

    To evaluate the ability of the affected shoulder to perform daily live activities. The tool is based on 12 "yes" (1 point) or "no" (0 points) questions. Overall score is calculated by: \[number of "yes" / number of completex items\] x 100, were 0 % is the worst result, and 100% is the best result.

    Time frame: BASELINE, 12 WEEKS, 24 WEEKS

  8. Physiological fatigue - high density electromyography

    We are going to use a matrix of 64 electrodes located on middle deltoid muscle. The variables extracted will be: impulse train, motor neuron recruitment,, neural drive speed

    Time frame: Baseline, 6 Weeks, 12 weeks, 24 weeks.

  9. Kinematics - Motion capture system

    We are going to record analytical movements (forward flexion, lateral abduction, scaption) and functional movements with a mobile phone camera, to analyze position, linear acceleration and angular velocity

    Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks.

07

Study locations

1 of 1 sites recruiting
  • Antonio Cuesta Vargas
    Málaga, Spain
    Recruiting
    • Antonio Ignacio, Cuesta Vargas, PhD · Contactacuesta@uma.es · 952137551
    • Cuesta Vargas A Antonio Ignacio, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Jun 2026, 9 months after the start.

Of 27 interventional studies with no phase under Shoulder Fractures, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 26 and three quarters within 83. This study's planned 9 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 4, 2024
First posted
Apr 10, 2024
StartActual
Sep 1, 2025
Primary completionEst.
Jun 2026
CompletionEst.
Dec 2027
Last update
Apr 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06357143
Responsible party
Dr. Antonio I Cuesta-Vargas (Principal Investigator, University of Malaga) — Principal investigator
First posted
Apr 10, 2024
Start date
Sep 1, 2025
Primary completion
Jun 2026 (estimated)
Completion
Dec 2027 (estimated)
Last update
Apr 8, 2026

Study contacts

Antonio I Cuesta-Vargas, PhD
Contact
acuesta@uma.es
(+34) 667 45 55 44

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion